Skip to main content
. 2019 Dec 13;16(24):5092. doi: 10.3390/ijerph16245092

Table 3.

Values of the analyzed parameters allowing to assess the patency of small bronchi of both analyzed groups.

Parameter Date of the Examination Control Group Study Group p Value
MEF50 (%) I 85.48 ± 27.68
(74.05–96.91)
97.96 ± 23.30
(88.12–107.80)
>0.05
II 83.28 ± 25.55
(74.73–95.83)
99.92 ± 34.89
(85.18–114.66)
>0.05
III 87.52 ± 26.09
(76.75–98.29)
101.08 ± 27.03
(89.66–112.50)
>0.05
IV 91.04 ± 28.73
(79.18–102.90)
97.25 ± 22.87
(87.69–107.01)
>0.05
V 82.76 ± 25.54
(72.22–93.30)
87.88 ± 20.45
(79.24–96.52)
>0.05
VI 81.64 ± 25.11
(71.27–92.01)
90.75 ± 19.83
(82.38–99.12)
>0.05
PEF (%) I 86.76 ± 19.91
(78.54–94.98)
96.42 ± 21.10
(87.51–105.33)
>0.05
II 75.04 ± 19.10
(67.16–82.92)
90.25 ± 26.12
(79.22–101.28)
<0.05
III 85.36 ± 19.25
(77.41–93.31)
98.88 ± 25.43
(88.14–109.62)
<0.05
IV 86.92 ± 19.05
(79.06–94.78)
100.25 ± 27.49
(88.64–111.86)
≥0.05
V 83.92 ± 17.89
(76.54–91.30)
94.38 ± 23.61
(84.41–104.35)
>0.05
VI 81.64 ± 16.48
(74.84–88.44)
95.88 ± 21.81
(86.67–105.09)
<0.05

Values are mean ± SD (confidence intervals 95%). MEF50: maximal expiratory flow at 50%, PEF: peak expiratory flow.